Home / Brands / Stason Pharmaceuticals
Stason Pharmaceuticals Recalls
2 recalls on record · September 14, 2016 to March 13, 2024 · Drugs
Recalls by year
16
24
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
March 13, 2024DrugsFDA
Stason Pharmaceuticals, Inc. recalls Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-91
Hazard: Failed Dissolution Specifications: results slightly under spec at at 9-months.
September 14, 2016DrugsFDA
Stason Pharmaceuticals, Inc. recalls Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: Stason Pharmaceuticals, Inc. Irvine, CA 926
Hazard: Stason Pharmaceuticals is recalling Selegiline HCl tablets, USP 5mg 60 count bottle due to an out of specification result for dissolution of stability samples.